SSgA Funds Management, Inc. has recently announced that it has increased stake in NuVasive Inc. (NASDAQ:NUVA) by 1.16%. After grabbing 2.14 million shares, the institutional investor is now in possession of 24563.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.09% having worth around $92.25 million. Moreover, Magnetar Financial LLC increased its share by 0.93 million to have a control over 1.78 million shares. And Dimensional Fund Advisors LP raised its holdings to 0.11 million shares by acquiring 1.56 million shares or 2.98% of the stake.
NuVasive Inc. (NUVA) concluded trading on 05/25/23 at a closing price of $37.39, with 1.16 million shares of worth about $43.2 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 0.67% during that period and on Thursday the price saw a loss of about -0.56%. Currently the company’s common shares owned by public are about 52.24M shares, out of which, 52.02M shares are available for trading.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 16 analysts are covering the NUVA stock and their offered price forecasts bring an average price target of $49.06. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $58.00 and could fall to a lowest price of $43.00. The stock’s current price level is 23.66% above of average price target set by the analysts, while a rise to estimated low would result in gain of 13.05% for the stock. However, touching the estimated high of $58.00 would mean a gain of 35.53% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 16 times over the past 12 months. They bought 66,685 shares in 9 of the transactions. In 7 selling transactions, insiders dumped 20,396 shares.
iShares Core S&P Small Cap ETF, Vanguard Total Stock Market ETF, and Vanguard Small Cap Index Fund are the top 3 mutual funds which are holding stakes in NuVasive Inc. iShares Core S&P Small Cap ETF is currently holding 3.79 million shares of worth totaling $162.97 million. The company recently came selling 5236.0 shares which brought its stake up to 7.23% of the company’s outstanding shares. Vanguard Total Stock Market ETF bought 20597.0 shares, after which its hold over company’s outstanding shares expand to 3.10%, leaving 1.62 million shares with the mutual fund that have a worth of about $69.85 million. Vanguard Small Cap Index Fund, after selling 1.37 million shares, have now control over 2.61% of the stake in the company. It holds 336.0 shares of worth $58.77 million.
NuVasive Inc. (NASDAQ: NUVA) started trading at $37.51, below -$0.09 from concluding price of the previous day. However, the stock later moved at a day high price of 37.51, or with a loss of -0.56%. Stock saw a price change of -8.22% in past 5 days and over the past one month there was a price change of -12.46%. Year-to-date (YTD), NUVA shares are showing a performance of -9.34% which decreased to -32.22% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $35.17 but also hit the highest price of $58.55 during that period. The average intraday trading volume for NuVasive Inc. shares is 961.86K. The stock is currently trading -9.43% below its 20-day simple moving average (SMA20), while that difference is down -8.60% for SMA50 and it goes to -12.36% lower than SMA200.
SSgA Funds Management, Inc. acquired 2.14 million shares of NuVasive Inc. having value of about $92.25 million. Data submitted at the U.S SEC by SSgA Funds Management, Inc. revealed that the firm now holds 24563.0 shares in the company valued at close to $918410.57, or have control over 1.16% stake in the company. NuVasive Inc. (NASDAQ: NUVA) currently have 52.24M outstanding shares and institutions hold larger chunk of about 112.85% of that. Holding of mutual funds in the company is about 39.86% while other institutional holders and individual stake holders have control over 64.28% and 15.41% of the stake respectively.
The stock has a current market capitalization of $2.00B and its 3Y-monthly beta is at 1.08. PE ratio of stock for trailing 12 months is 143.81, while it has posted earnings per share of $0.26 in the same period. Its PEG reads 8.41 and has Quick Ratio of 0.70 while making debt-to-equity ratio of 1.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NUVA, volatility over the week remained 2.82% while standing at 2.39% over the month.
Analysts are in expectations that NuVasive Inc. (NUVA) stock would likely to be making an EPS of $0.55 in the current quarter, while forecast for next quarter EPS is $0.54 and it is $2.56 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.48 which is $0.6 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.47 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 156.70% while it is estimated to increase by 17.56% in next year. EPS is likely to grow at an annualized rate of 17.10% for next 5-years, compared to annual growth of -8.90% made by the stock over the past 5-years.
Analysts at 16 brokerage firms have issued recommendations for the NuVasive Inc. (NUVA)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.70. Out of those 16 Wall Street analysts, 3 recommended a “Buy” rating, while 12 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Leave a Reply